Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of James Leigh Hsu
Introduction
James Leigh Hsu is a notable inventor based in San Diego, California. He has made significant contributions to the field of ocular disease treatment through his innovative research and development. His work focuses on the application of anti-S1P antibodies in addressing various ocular conditions.
Latest Patents
Hsu holds a patent for an "Anti-S1P antibody treatment of patients with ocular disease." This invention involves methods for administering an anti-S1P antibody or its derivatives to individuals suffering from ocular diseases, particularly those involving choroidal neovascularization. The patent outlines the desired effects of the treatment, which include reducing the size of choroidal neovascularization lesions, decreasing retinal pigment epithelial detachment, and improving visual acuity. The pharmaceutical compositions developed are especially beneficial for patients with age-related macular degeneration.
Career Highlights
James Leigh Hsu is associated with Lpath, Inc., where he continues to advance his research in ocular therapies. His work has the potential to significantly impact the treatment of ocular diseases, providing new hope for patients suffering from conditions that affect their vision.
Collaborations
Hsu collaborates with esteemed colleagues, including Glenn L Stoller and Marina Safonov, to further enhance the research and development of innovative treatments in the field of ophthalmology.
Conclusion
James Leigh Hsu's contributions to ocular disease treatment through his patented innovations exemplify the importance of research in improving patient outcomes. His work continues to pave the way for advancements in the field of ophthalmology.